Literature DB >> 26597742

Cerebrovascular, cardiovascular and renal hypertensive disease after hypertensive disorders of pregnancy.

S A M Schokker1, M F Van Oostwaard2, E M Melman3, J P Van Kessel3, M I Baharoglu4, Y B W E M Roos4, L Vogt5, R J De Winter6, B W Mol7, W Ganzevoort3.   

Abstract

BACKGROUND: Strong associations have been established in nationwide registry studies between hypertensive disorders of pregnancy (HDP) and later vascular morbidities and mortality. The aim of this case-control study is to examine the interdependent relationships of different predictive factors for vascular disease and HDP, because they are not clearly elucidated due to lack of detail in registries. METHODS AND
RESULTS: We assembled three different case groups of women who had cerebrovascular, cardiovascular, or hypertensive kidney disease before the age of 55. The control group consisted of age-matched women who underwent hysterectomy for benign reasons. We assessed the occurrence of HDP in previous pregnancies. The strength of the association with vascular morbidities was tested with multivariable logistic regression in comparison with classic vascular risk factors. In all case groups, previous HDP occurred more frequent than in the control group. In logistic regression analysis, previous HDP were the strongest predictor in the cerebrovascular group (OR 4.2; 95% confidence interval [CI] 1.6-11.0). In the cardiovascular group and the kidney failure group a similar association was found, however, this was not statistically significant (OR 4.4 (95% CI 0.82-4) and 2.9 (95% CI 0.61-14), respectively).
CONCLUSIONS: Previous hypertensive disorders of pregnancy are a strong predictor for later vascular morbidity. This is partially mediated through the presence of classic vascular risk factors, but our data suggest it is also an independent predictor.
Copyright © 2015 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Gestational hypertension; Hypertensive kidney failure; Percutaneous transluminal coronary angioplasty; Predictors; Preeclampsia; Stroke

Mesh:

Year:  2015        PMID: 26597742     DOI: 10.1016/j.preghy.2015.06.002

Source DB:  PubMed          Journal:  Pregnancy Hypertens        ISSN: 2210-7789            Impact factor:   2.899


  7 in total

1.  How we deliver obstetric care.

Authors:  Laura A Magee; Sandra Lowe; Catherine Nelson-Piercy
Journal:  Obstet Med       Date:  2016-06-01

Review 2.  Assessing and Modifying Coronary Artery Disease Risk in Women.

Authors:  Amy Sarma; Nandita S Scott
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-07

Review 3.  Ischemic stroke and cerebral venous sinus thrombosis in pregnancy.

Authors:  Hannah J Roeder; Jean Rodriguez Lopez; Eliza C Miller
Journal:  Handb Clin Neurol       Date:  2020

4.  The Effect of Dexmedetomidine on Oxidative Stress Response Following Cerebral Ischemia-Reperfusion in Rats and the Expression of Intracellular Adhesion Molecule-1 (ICAM-1) and S100B.

Authors:  Yanwen Li; Shikun Liu
Journal:  Med Sci Monit       Date:  2017-02-17

Review 5.  Use of Race, Ethnicity, and National Origin in Studies Assessing Cardiovascular Risk in Women With a History of Hypertensive Disorders of Pregnancy.

Authors:  Amy Johnston; Victrine Tseung; Sonia R Dancey; Sarah M Visintini; Thais Coutinho; Jodi D Edwards
Journal:  CJC Open       Date:  2021-08-20

6.  Impact of Hypertensive Disorders of Pregnancy on the Risk of Stroke Stratified by Subtypes and Follow-Up Time.

Authors:  Shih-Kai Hung; Moon-Sing Lee; Hon-Yi Lin; Liang-Cheng Chen; Chi-Jou Chuang; Chia-Hui Chew; Ben-Hui Yu; Hsuan-Ju Yang; Feng-Chun Hsu; Wen-Yen Chiou
Journal:  Stroke       Date:  2022-01-05       Impact factor: 7.914

7.  The Association Between Hypertensive Disorders in Pregnancy and the Risk of Developing Chronic Hypertension.

Authors:  Jiahao Xu; Ting Li; Yixiao Wang; Lu Xue; Zhijing Miao; Wei Long; Kaipeng Xie; Chen Hu; Hongjuan Ding
Journal:  Front Cardiovasc Med       Date:  2022-07-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.